From Pre-Clinical To Vet-Clinical Imaging and Therapy: Pathways to Clinical Translation
K Wang1*, J Wong2*, P Basran3*, D Leary4*, K Selting5*, (1) UT Southwestern Medical Center, Dallas, TX, (2) Johns Hopkins University, Baltimore, MD, (3) Cornell University, Ithaca, NY, (4) Colorado State University, Fort Collins, CO, (5) University of Illinois, Urbana-champagne, IL
Presentations
WE-A-BRC-0 (Wednesday, 7/13/2022) 7:30 AM - 8:30 AM [Eastern Time (GMT-4)]
Ballroom C
There is a spectrum of in vivo animals models and their relationship with human healthcare. On one end of the spectrum, small animals, such as mice, may be used in the early development of untested imaging and treatment technologies to demonstrate efficacy, assess proof of principle, and evaluate safety. On the other end of the spectrum, companion animals, such as dogs and cats, may be used in pre-human trials prior to Food and Drug Administration approvals of technologies and treatments. The last decade has seen substantial developments of in vivo small animal imaging and radiotherapy treatment devices, and leading-edge technologies and treatments are commonplace in the veterinary setting. The purpose of this session is to describe this spectrum of in vivo imaging and treatment in animal models, with a focus on their connections with medical physics.
Learning Objectives:
1. Understand the recent developments in small animal imaging and treatment devices
2. Understand developments of ultra-high dose rate (FLASH) irradiation in small animals
3. Describe the state of the art in veterinary radiation oncology and medical physics
4. Gain insight on the veterinary radiation oncologist’s perspective of clinical translation
Handouts
- 175-63147-16291659-184036-527829776.pdf (Ken Kang-Hsin Wang)
- 175-66974-16291659-184036-490135046.pdf (Ken Kang-Hsin Wang)
Keywords
Not Applicable / None Entered.
Taxonomy
TH- Small Animal RT: General (most aspects)
Contact Email